Paper39104192
The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype.
Herndon ME and 6 others. Dis Model Mech, 2024. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. The highly metastatic 4T1 breast carcinoma model possesses features of a hybrid epithelial/mesenchymal phenotype. Papers, record 39104192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39104192
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Epithelial-Mesenchymal Transition | Major topic |
| Cadherins | Major topic |
| Phenotype | Major topic |
| Neoplasm Metastasis | Major topic |
| Animals | |
| Female | |
| Cell Line, Tumor | |
| Mice | |
| Neoplasm Invasiveness | |
| Breast Neoplasms | |
| Mice, Inbred BALB C | |
| Disease Models, Animal | |
| Intercellular Junctions | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA086862 | NCI NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| P30 CA086862 | NIH HHS | United States | P30CA086862 | PubMed and NIH | NIH RePORTER |
| University of Iowa | PubMed | PubMed | |||
| Holden Comprehensive Cancer Center, University of Iowa | PubMed | PubMed |
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36768838 | GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768838 | PubMed |
| 2 | 30228301 | Stem cell fate in cancer growth, progression and therapy resistance. | Nat Rev Cancer | 2018 | https://conductscience.org/library/papers/30228301 | PubMed |
| 3 | 28455959 | OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis. | Oncotarget | 2017 | https://conductscience.org/library/papers/28455959 | PubMed |
| 4 | 16024595 | Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? | Cancer Res | 2005 | https://conductscience.org/library/papers/16024595 | PubMed |
| 5 | 23201165 | Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. | Cancer Cell | 2012 | https://conductscience.org/library/papers/23201165 | PubMed |
| 6 | 24202396 | The epigenetics of epithelial-mesenchymal plasticity in cancer. | Nat Med | 2013 | https://conductscience.org/library/papers/24202396 | PubMed |
| 7 | 15210113 | Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. | Cell | 2004 | https://conductscience.org/library/papers/15210113 | PubMed |
| 8 | 28096261 | Tuning Collective Cell Migration by Cell-Cell Junction Regulation. | Cold Spring Harb Perspect Biol | 2017 | https://conductscience.org/library/papers/28096261 | PubMed |
| 9 | 26947068 | Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity. | Cell Rep | 2016 | https://conductscience.org/library/papers/26947068 | PubMed |
| 10 | 9700170 | Adhesive but not lateral E-cadherin complexes require calcium and catenins for their formation. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9700170 | PubMed |
| 11 | 10037790 | Coupling assembly of the E-cadherin/beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells. | J Cell Biol | 1999 | https://conductscience.org/library/papers/10037790 | PubMed |
| 12 | 21822286 | Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. | Nat Med | 2011 | https://conductscience.org/library/papers/21822286 | PubMed |
| 13 | 25203322 | PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. | Cancer Cell | 2014 | https://conductscience.org/library/papers/25203322 | PubMed |
| 14 | 33902034 | Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications. | Cells Tissues Organs | 2022 | https://conductscience.org/library/papers/33902034 | PubMed |
| 15 | 18485877 | The epithelial-mesenchymal transition generates cells with properties of stem cells. | Cell | 2008 | https://conductscience.org/library/papers/18485877 | PubMed |
| 16 | 23201163 | Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. | Cancer Cell | 2012 | https://conductscience.org/library/papers/23201163 | PubMed |
| 17 | 21460854 | miR-155 promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT. | Oncogene | 2011 | https://conductscience.org/library/papers/21460854 | PubMed |
| 18 | 19487818 | The basics of epithelial-mesenchymal transition. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19487818 | PubMed |
| 19 | 22554795 | Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22554795 | PubMed |
| 20 | 18483246 | Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. | Cancer Res | 2008 | https://conductscience.org/library/papers/18483246 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42639567 | Preparation and Evaluation of Docetaxel-Loaded Targeted Poly (β‑amino Ester) - Magnetic Nanoparticles for Chemo‑Magnetodynamic Therapy Under Low‑Frequency Magnetic Fields. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42639567 | PubMed |
| 41809619 | Combined Treatment with Shuyu Pills and Everolimus Suppresses Triple-Negative Breast Cancer Growth via the PI3K/AKT/mTOR Pathway. | Breast Cancer (Dove Med Press) | 2026 | https://conductscience.org/library/papers/41809619 | PubMed |
| 41235687 | C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBC. | Oncol Rep | 2026 | https://conductscience.org/library/papers/41235687 | PubMed |
| 41220296 | Photosensitizing Lipid Nanoparticles for Ferroptosis-Enhanced Photodynamic Cancer Therapy via GPX4 Silencing. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41220296 | PubMed |
| 41155896 | Homotypic Targeting of [89Zr]Zr-Oxine Labeled PC3 and 4T1 Cells in Tumor-Bearing Mice. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41155896 | PubMed |
| 40481460 | Automatic target-seeking nanoparticle inhibiting orthotopic drug-resistant colon cancer and liver metastases via regulating cancer cell adhesion and proliferation. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40481460 | PubMed |
| 40473829 | Collective migration modes in development, tissue repair and cancer. | Nat Rev Mol Cell Biol | 2025 | https://conductscience.org/library/papers/40473829 | PubMed |
| 39671143 | FNDC1 Facilitates Proliferation, Migration, and Invasion of Breast Cancer Cells Through Modulating Wnt/β-Catenin Pathway. | Biochem Genet | 2025 | https://conductscience.org/library/papers/39671143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39104192
GET https://conductscience.org/api/papers/v1/39104192/references?page=2